According to Sina Finance, citing Shanghai Securities News, third-quarter 13F filings showed major investment firms cutting positions in broad U.S. stock ETFs and reallocating within technology and toward defensive sectors. Bridgewater reduced its holdings in the SPDR S&P 500 ETF and iShares Core S&P 500 ETF by 36% and 50%, respectively, while Renaissance Technologies sold all 219,000 of its SPDR S&P 500 ETF shares. Millennium Management cut its position in that fund from 4.857 million shares to 2.4 million. Barclays reduced its SPDR S&P 500 ETF holdings by 11% and its Nasdaq-100 ETF holdings by 47%; JPMorgan cut its Nasdaq-100 ETF position by 22%.
Renaissance Technologies sharply reduced its holdings in Nvidia, Apple, Amazon and Meta, while increasing its Micron position from 210,000 shares to 1.52 million, AMD from 830,000 to 2 million, and Sandisk from 4,980 to 276,500. Bridgewater also cut its Nvidia, Amazon, Alphabet and Microsoft holdings, while more than doubling its Micron position and increasing its Sandisk stake from 317 shares to 66,800.
Fidelity International increased holdings in AstraZeneca, Agnico Eagle Mines and Bank of Nova Scotia. UBS opened a position of 13.81 million shares in Exxon Mobil and added 610,000 Chevron shares. BlackRock, Vanguard Capital Management and State Street Group also increased their Coca-Cola holdings. As of November 17, AstraZeneca and Coca-Cola had each gained more than 10% since October. Barclays upgraded U.S. health care to “positive” from “neutral” on November 16, citing favorable demand and rising earnings expectations. Standard Chartered recommended diversification across technology, financials, health care and high-dividend stocks in an early-November strategy view.